 LEXINGTON, Mass.--BUSINESS WIRE--Cyteir Therapeutics, Inc. Cyteir Nasdaq: CYT, a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, announced that its President and Chief Executive Officer Markus Renschler, MD will participate in the 2021 Wedbush PacGrow Healthcare Conference, being held virtually on August 10, 2021. 12th Annual Wedbush PacGrow Healthcare Virtual Conference Date: Tuesday, August 10 Time: 11:30 AM EDT Panel: Syn 